Ex Parte DORSCHUG et al - Page 7


                Appeal No. 2001-1586                                                                      Page 7                            
                Application No. 08/402,394                                                                                                     

                since it is teachings in the references or knowledge generally available in the art that                                       
                must suggest the desirability of combining the teachings in order to arrive at the claimed                                     
                subject matter.  Here, the examiner’s reasoning is premised upon one of ordinary skill in                                      
                the art reading the disclosure of the genus of proinsulin compounds in Markussen ‘212                                          
                throught the lens of Grau ‘332.  However, we do not find the lens of Grau ’322 to be as                                        
                sharply focused as does the examiner.                                                                                          
                         The examiner has not analyzed Grau ‘332 in regard to the intermediates taught                                         
                or suggested by the reference that would be useful in preparing the final products of the                                      
                reference such as insulin-Arg B31-OH.  If the selection of the compound of claim 33 to                                         
                use as the intermediate in preparing insulin-Arg B31-OH would have been obvious, it                                            
                seems that it would have been obvious from a consideration of Grau ‘322 alone on the                                           
                basis of working backwards from a given desired end product and preparing a list of                                            
                intermediate insulin derivatives which would result in the desired end product after                                           
                tryptic digestion.  For example, Example 2 of Grau ‘322 uses monkey preproinsulin to                                           
                form insulin-Arg B31-OH.  It is unclear how large the list of possible intermediates is, as                                    
                the examiner’s analysis did not follow this path.  It may be that, viewed in this light, the                                   
                list of possible insulin intermediates that are capable of forming insulin-Arg B31-OH by                                       
                way of tryptic digestion is quite large.  If so, one is put in the same position as one is in                                  
                viewing the large genus of insulin compounds described by Markussen ‘322.  Instead of                                          
                analyzing Grau ‘322 in this light, the examiner’s analysis jumps immediately to                                                
                apparently the only species of the possible millions of compounds generically described                                        

                                                                                                                                               
                on throughout the remainder of the document.  References to page numbers of the Examiner’s Answer                              
                are based upon the actual page numbers of the record document.                                                                 





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007